Detalles de la búsqueda
1.
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv).
Br J Cancer
; 128(5): 877-885, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36482190
2.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): 341-347, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33355953
3.
Prognostic impact of regression in patients with primary cutaneous melanoma >1 mm in thickness.
J Am Acad Dermatol
; 80(1): 99-105.e5, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30447951
4.
Immunomodulating property of MAPK inhibitors: from translational knowledge to clinical implementation.
Lab Invest
; 97(2): 166-175, 2017 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27991907
5.
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases.
J Am Acad Dermatol
; 76(2): 264-273.e2, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27847125
6.
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international study.
Eur J Cancer
; 199: 113542, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38266540
7.
Pancreatic ductal adenocarcinoma complete regression after preoperative chemotherapy: Surgical results in a small series.
Cancer Treat Res Commun
; 37: 100770, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37837717
8.
Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience.
Updates Surg
; 75(1): 159-167, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36371549
9.
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile.
Eur J Cancer
; 191: 113246, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37549531
10.
Discontinuation of anti-PD1 in advanced melanoma: an observational retrospective study from the Italian Melanoma Intergroup.
Eur J Cancer
; 187: 25-35, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37099946
11.
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors.
J Am Acad Dermatol
; 74(6): 1254-1256.e4, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27185428
12.
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
J Immunother Cancer
; 9(2)2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33593827
13.
Screening and diagnosis for colorectal cancer: present and future.
Tumori
; 96(6): 889-901, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21388049
14.
Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study.
J Immunother Cancer
; 8(2)2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33203662
15.
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI).
Eur J Cancer
; 137: 30-39, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32739767
16.
Tumor CD155 Expression Is Associated with Resistance to Anti-PD1 Immunotherapy in Metastatic Melanoma.
Clin Cancer Res
; 26(14): 3671-3681, 2020 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32345648
17.
Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis.
Melanoma Res
; 29(1): 1-12, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30308577
18.
Combination of radiotherapy and immunotherapy for brain metastases: A systematic review and meta-analysis.
Crit Rev Oncol Hematol
; 144: 102830, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733443
19.
Health-related quality of life in patients with fully resected BRAFV600 mutation-positive melanoma receiving adjuvant vemurafenib.
Eur J Cancer
; 123: 155-161, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31704549
20.
Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program.
Melanoma Res
; 29(5): 527-532, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31095039